News
Five year survival doubles for younger women with de novo MBC
With more women than ever surviving MBC, how will long-term care be affected?
News
Salvage chemo for NSCLC more effective after PD-1/PD-L1 inhibitors
GENEVA – Salvage chemotherapy was more effective among patients who had disease progression following immunotherapy in the second line than among...
News
Atezolizumab improves OS in NSCLC with brain metastases
GENEVA – Immune checkpoint inhibitors may improve survival in patients with non–small cell lung cancer (NSCLC) and brain metastases compared with...
News
Second generation ALK inhibitors show good response in second-line NSCLC
GENEVA – Investigators presented results from a retrospective review of outcomes in patients with ALK-positive NSCLC treated at one of four Swiss...
News
Lung cancer metastatic sites differ by histology, tumor factors
GENEVA – Distinct metastasis patterns emerge in patients with lung cancer, though the study was limited to patients who already has metastasis.
News
G-CSF safe, but antibiotics are more concerning in SCLC
GENEVA – Despite some negative outcomes with G-CSF, it seems to be the preferred treatment over antibiotics.
News
Chemo sequencing in elderly adults with NSCLC linked with survival
GENEVA – Which sequences have the best effects, and why might that be?
News
Sex-based differences in lung cancer screening intervals suggested
Prior studies to see whether longer screening intervals were safe have yielded mixed results, possibly because of differences in clinical and...
News
Flu shots may spark immune adverse events in PD-1 blockade for NSCLC
GENEVA – More than half of patients who had received a trivalent influenza vaccine in a small study had immune-related adverse events.
News
MRD better measure of ALL remission than morphology
MONTREAL – Minimal residual disease is better than morphology at determining remission in acute lymphoblastic leukemia remission, but using both...
News
Game over: VTE is a risk in obese, sedentary teens
MONTREAL – We all know about the risk of VTE on planes. What about that for obese children and adolescents?
News
Could refractory T-ALL be daratumumab’s next frontier?
MONTREAL – Six of seven mouse models of early T-precursor T-ALL responded to daratumumab injections.
News
Watchful waiting a suitable option for pediatric acute ITP
MONTREAL – Treatment of acute idiopathic thrombocytopenic purpura does not appear to increase risk of later chronic ITP, except in children up to...
News
In sickle cell disease, osteomyelitis is a tough call
MONTREAL – How could ESR change osteomyelitis diagnosis in patients with SCD?